スマートシリンジの世界市場：治療法、用途、エンドユーザー別-2025年～2030年予測

スマートシリンジ市場は、2023年に84億4,000万米ドルと評価され、2024年には104億6,000万米ドルに達すると予測され、CAGR 24.61%で成長し、2030年には393億8,000万米ドルに達すると予測されています。

スマートシリンジは、医療現場における安全性と効率性を高めるために設計された革新的な医療機器です。従来の注射器とは異なり、スマートシリンジには、再使用や針刺し事故を防止するために設計された自動無効化、受動的または能動的な安全機構などの機能が搭載されており、汚染やHIVや肝炎などの感染症の拡大といった重大な医療上の懸念に対処しています。スマートシリンジの必要性は、医療従事者のシャープスによる傷害を減らすために注射の安全性を提唱する世界の保健政策に起因しており、その結果、医療現場全体で需要が高まっています。スマートシリンジは主に病院、診療所、外来手術センターで使用され、最終用途は特に予防接種プログラム、治療用注射、ドラッグデリバリーシステムに広がっています。スマートシリンジ市場の主な成長要因は、注射製剤が重視されるようになったこと、繰り返し安全な薬物送達が必要とされる慢性疾患が増加していること、安全工学機器の使用を促進する厳しい政府規制があることです。潜在的なビジネスチャンスとしては、治療プロトコルの遵守を強化するIoT対応注射器や、効果的な在庫管理のためのGPS統合ソリューションなどのスマート技術の進歩に加え、ヘルスケア・インフラ投資が拡大する開発市場の開拓が挙げられます。しかし、従来の注射器と比べてコストが高い、低所得地域では認知度が低い、伝統的な医療慣行の変化による抵抗がある、といった課題が市場の成長を阻害する可能性があります。革新的な技術としては、コスト効率の高い生産ソリューション、スマート・ドラッグデリバリーと電子カルテの統合による追跡の向上、持続可能性を高めるための環境に優しい素材開発などが挙げられます。市場は現在、急速な技術進歩、規制状況の変化、ヘルスケアの安全性に対する意識の高まりを特徴とするダイナミックな環境を示しており、競争上の優位性を維持し、将来の発展に影響を与えることを目指す市場プレーヤーにとって、研究開発への戦略的投資やハイテク企業との提携の機が熟しています。

市場力学：急速に進化するスマートシリンジ市場の主要市場インサイトを公開

スマートシリンジ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 各種対象疾患の有病率の上昇と高齢者人口の増加
  • ワクチン接種キャンペーンとイニシアチブの増加
  • ヘルスケア関連感染の発生と針刺し損傷の増加
• 市場抑制要因
  • スマートシリンジ製品リコール
• 市場機会
  • 環境安全性と自動無効化シリンジへのニーズの高まり
  • 患者の健康と安全に対する厳しい規制
• 市場の課題
  • 新興諸国におけるスマートシリンジの認知度と使用率の低さ

ポーターの5つの力：スマートシリンジ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、スマートシリンジ市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：スマートシリンジ市場における外部からの影響の把握

外部マクロ環境要因は、スマートシリンジ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析スマートシリンジ市場における競合情勢の把握

スマートシリンジ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックススマートシリンジ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、スマートシリンジ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • さまざまな対象疾患の罹患率の上昇と高齢者人口の増加
    • ワクチン接種キャンペーンや取り組みの増加
    • 医療現場での感染の主な事例と針刺し事故の増加
  • 抑制要因
    • スマートシリンジ製品リコール
  • 機会
    • 環境に安全で自動無効化機能を備えた注射器の需要の高まり
    • 患者の健康と安全に関する厳格な規制
  • 課題
    • 新興諸国におけるスマートシリンジの認知度と使用率の低さ
• 市場セグメンテーション分析
  • 治療：予防接種キャンペーンにおける自動無効化注射器の使用増加
  • 応用：ドラッグデリバリーにおけるスマートシリンジの幅広い応用性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 スマートシリンジ市場：治療法別

• アクティブセーフティシリンジ
• 注射器を自動無効化
• パッシブセーフティシリンジ

第7章 スマートシリンジ市場：用途別

• 血液検体採取
• ドラッグデリバリー
• 予防接種

第8章 スマートシリンジ市場：エンドユーザー別

• 診断センター
• 病院とHMO
• 医師クリニック

第9章 南北アメリカのスマートシリンジ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のスマートシリンジ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのスマートシリンジ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • テルモインド、毎日インスリン注射が必要な患者向けにインスリン注射器を導入
  • シャープス・テクノロジー、インジェクトEZ特殊コポリマー注射器製造施設の買収に関する資産購入契約およびネフロン・ファーマシューティカルズからの4億米ドル超の10年購入契約を締結
  • ステバナートグループがトランスコジェクトと提携し、製薬業界向けにプレフィルドシリンジポリマーのオプションを提供

企業一覧

• Shanghai Kohope Medical Co., Ltd.
• Hindustan Syringes & Medical Devices Ltd.
• MHC Medical Products, LLC
• Shimadzu Corporation
• Biocorp by Novo Nordisk A/S
• Sharps Technology, Inc.
• Stevanato Group
• Cardinal Health, Inc.
• Owen Mumford Limited
• Tecan Group Ltd.
• B. Braun SE
• Vogt Medical Vertrieb GmbH
• Sol-Millennium Medical Group
• AdvaCare Pharma
• Agilent Technologies, Inc.
• Baxter International Inc.
• Gerresheimer AG
• Numedico Technologies Pty Ltd.
• Thermo Fisher Scientific Inc.
• UltiMed, Inc.
• Terumo Corporation
• Revolutions Medical Corporation
• Medtronic PLC
• Retractable Technologies, Inc.
• Parker-Hannifin Corporation
• Becton, Dickinson and Company
• DMC Medical Limited
• Smiths Group PLC

LIST OF FIGURES

• FIGURE 1. SMART SYRINGES MARKET RESEARCH PROCESS
• FIGURE 2. SMART SYRINGES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SMART SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SMART SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SMART SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SMART SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SMART SYRINGES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SMART SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SMART SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SMART SYRINGES MARKET DYNAMICS
• TABLE 7. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SMART SYRINGES MARKET SIZE, BY ACTIVE SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SMART SYRINGES MARKET SIZE, BY AUTO-DISABLE SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SMART SYRINGES MARKET SIZE, BY PASSIVE SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SMART SYRINGES MARKET SIZE, BY BLOOD SPECIMEN COLLECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SMART SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SMART SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SMART SYRINGES MARKET SIZE, BY DIAGNOSTICS CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SMART SYRINGES MARKET SIZE, BY HOSPITALS & HMOS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SMART SYRINGES MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 30. CANADA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 47. CHINA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 50. INDIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 102. ITALY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 114. POLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 117. QATAR SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. SMART SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. SMART SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

The Smart Syringes Market was valued at USD 8.44 billion in 2023, expected to reach USD 10.46 billion in 2024, and is projected to grow at a CAGR of 24.61%, to USD 39.38 billion by 2030.

Smart syringes are innovative medical devices engineered to enhance safety and efficiency in medical practices. Unlike traditional syringes, smart syringes are equipped with features such as auto-disable, passive or active safety mechanisms designed to prevent re-use and needle stick injuries, addressing critical healthcare concerns such as contamination and the spread of infections like HIV and Hepatitis. The necessity for smart syringes arises from global health policies advocating for safety in injection practices to reduce sharps injuries among healthcare workers, subsequently driving their demand across healthcare settings. They are predominantly utilized in hospitals, clinics, and ambulatory surgical centers, with end-use extending particularly to immunization programs, therapeutic injections, and drug delivery systems. A major growth factor in the smart syringe market is the rising emphasis on injectable formulations, increasing incidences of chronic diseases necessitating repeated and safe medication delivery, coupled with stringent government regulations promoting the use of safety-engineered devices. Potential opportunities include advancements in smart technologies such as IoT-enabled syringes enhancing adherence to treatment protocols and GPS-integrated solutions for effective inventory management, alongside expanding markets in developing regions with growing healthcare infrastructure investments. However, challenges such as high costs compared to traditional syringes, limited awareness in low-income regions, and resistance due to changes in traditional medical practices may hinder market growth. Innovations could focus on cost-effective production solutions, integrating smart drug delivery with electronic health records for better tracking, and eco-friendly material development to enhance sustainability. The market currently exhibits a dynamic environment characterized by rapid technological advancements, shifting regulatory landscapes, and an increasing awareness of healthcare safety, making it ripe for strategic investments in R&D and partnerships with tech companies for market players aiming to maintain competitive advantage and influence future developments.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Syringes Market

The Smart Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising Prevalence of Various Target Diseases and Growth of the Geriatic Population
  • Increasing Number of Vaccination Campaigns and Initiatives
  • Major incidents of Healthcare-Acquired Infections and Rise in Count of Needle Stick Injuries
• Market Restraints
  • Smart Syringes Product Recalls
• Market Opportunities
  • Growing Need for Environmentally Safe and Auto Disable Syringes
  • Stringent Regulation for Patient Health and Safety
• Market Challenges
  • Low Awareness and Usage of Smart Syringes in Developing Countries

Porter's Five Forces: A Strategic Tool for Navigating the Smart Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Syringes Market

A detailed market share analysis in the Smart Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Smart Syringes Market, highlighting leading vendors and their innovative profiles. These include Shanghai Kohope Medical Co., Ltd., Hindustan Syringes & Medical Devices Ltd., MHC Medical Products, LLC, Shimadzu Corporation, Biocorp by Novo Nordisk A/S, Sharps Technology, Inc., Stevanato Group, Cardinal Health, Inc., Owen Mumford Limited, Tecan Group Ltd., B. Braun SE, Vogt Medical Vertrieb GmbH, Sol-Millennium Medical Group, AdvaCare Pharma, Agilent Technologies, Inc., Baxter International Inc., Gerresheimer AG, Numedico Technologies Pty Ltd., Thermo Fisher Scientific Inc., UltiMed, Inc., Terumo Corporation, Revolutions Medical Corporation, Medtronic PLC, Retractable Technologies, Inc., Parker-Hannifin Corporation, Becton, Dickinson and Company, DMC Medical Limited, and Smiths Group PLC.

Market Segmentation & Coverage

This research report categorizes the Smart Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Theraupetics, market is studied across Active Safety Syringes, Auto-disable Syringes, and Passive Safety Syringes.
• Based on Application, market is studied across Blood Specimen Collection, Drug Delivery, and Vaccination.
• Based on End User, market is studied across Diagnostics Center, Hospitals & HMOs, and Physician Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Prevalence of Various Target Diseases and Growth of the Geriatic Population
    • 5.1.1.2. Increasing Number of Vaccination Campaigns and Initiatives
    • 5.1.1.3. Major incidents of Healthcare-Acquired Infections and Rise in Count of Needle Stick Injuries
  • 5.1.2. Restraints
    • 5.1.2.1. Smart Syringes Product Recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing Need for Environmentally Safe and Auto Disable Syringes
    • 5.1.3.2. Stringent Regulation for Patient Health and Safety
  • 5.1.4. Challenges
    • 5.1.4.1. Low Awareness and Usage of Smart Syringes in Developing Countries
• 5.2. Market Segmentation Analysis
  • 5.2.1. Therapeutics: Increasing use of auto-disable syringes for immunization campaigns
  • 5.2.2. Application: Wide applicability of smart syringes for drug delivery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Smart Syringes Market, by Theraupetics

• 6.1. Introduction
• 6.2. Active Safety Syringes
• 6.3. Auto-disable Syringes
• 6.4. Passive Safety Syringes

7. Smart Syringes Market, by Application

• 7.1. Introduction
• 7.2. Blood Specimen Collection
• 7.3. Drug Delivery
• 7.4. Vaccination

8. Smart Syringes Market, by End User

• 8.1. Introduction
• 8.2. Diagnostics Center
• 8.3. Hospitals & HMOs
• 8.4. Physician Clinics

9. Americas Smart Syringes Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Smart Syringes Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Smart Syringes Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections
  • 12.3.2. Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over USD 400 Million from Nephron Pharmaceuticals
  • 12.3.3. Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma

Companies Mentioned

• 1. Shanghai Kohope Medical Co., Ltd.
• 2. Hindustan Syringes & Medical Devices Ltd.
• 3. MHC Medical Products, LLC
• 4. Shimadzu Corporation
• 5. Biocorp by Novo Nordisk A/S
• 6. Sharps Technology, Inc.
• 7. Stevanato Group
• 8. Cardinal Health, Inc.
• 9. Owen Mumford Limited
• 10. Tecan Group Ltd.
• 11. B. Braun SE
• 12. Vogt Medical Vertrieb GmbH
• 13. Sol-Millennium Medical Group
• 14. AdvaCare Pharma
• 15. Agilent Technologies, Inc.
• 16. Baxter International Inc.
• 17. Gerresheimer AG
• 18. Numedico Technologies Pty Ltd.
• 19. Thermo Fisher Scientific Inc.
• 20. UltiMed, Inc.
• 21. Terumo Corporation
• 22. Revolutions Medical Corporation
• 23. Medtronic PLC
• 24. Retractable Technologies, Inc.
• 25. Parker-Hannifin Corporation
• 26. Becton, Dickinson and Company
• 27. DMC Medical Limited
• 28. Smiths Group PLC